According to Transgene SA's latest financial reports the company's current EPS (TTM) is -$3.16. In 2022 the company made an earnings per share (EPS) of -$0.47 a decrease over its 2021 EPS that were of -$0.31.
Year | EPS | Change |
---|---|---|
2022 | -$0.47 | 48.16% |
2021 | -$0.31 | -6.93% |
2020 | -$0.34 | -0.6% |
2019 | -$0.34 | -273.41% |
2018 | $0.20 | -124.48% |
2017 | -$0.80 | 31.82% |
2016 | -$0.61 | -63.87% |
2015 | -$1.68 | -14.59% |
2014 | -$1.97 | -17.15% |
2013 | -$2.37 | 2.99% |
2012 | -$2.30 | 0.3% |
2011 | -$2.30 | 8.93% |
2010 | -$2.11 | -7.32% |
2009 | -$2.28 | 56.96% |
2008 | -$1.45 | 176.84% |
2007 | -$0.52 | -77.81% |
2006 | -$2.36 | -41.86% |
2005 (TTM) | -$4.06 | 3.76% |
2004 | -$3.91 | 18.71% |
2003 | -$3.30 | 35.08% |
2002 | -$2.44 | -16.55% |
2001 | -$2.92 | -37.1% |
2000 | -$4.65 | 13.45% |
1999 | -$4.10 | -60.26% |
1998 | -$10.31 | 109.21% |
1997 | -$4.93 |